Hims & Hers Health, Inc. (NYSE: HIMS) reported Q1 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $101.3 million versus the consensus estimate of $91.17 million.

GUIDANCE:

Hims & Hers Health, Inc. sees FY2022 revenue of $103-106 million, versus the consensus of $92.45 million.

Hims & Hers Health, Inc. sees FY2022 revenue of $410-425 million, versus the consensus of $377.85 million.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.